Longeveron, Inc. (LGVN)
1.71
-0.07
(-3.93%)
USD |
NASDAQ |
Nov 05, 16:00
Longeveron Price : 1.71 for Nov. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 05, 2026 | 1.80 | 1.800 | 1.658 | 1.71 | 35078.00 |
| Nov 04, 2026 | 1.76 | 1.82 | 1.75 | 1.78 | 61409.00 |
| Nov 03, 2026 | 1.71 | 1.80 | 1.71 | 1.78 | 38178.00 |
| Nov 02, 2026 | 1.74 | 1.79 | 1.655 | 1.71 | 63489.00 |
| Oct 30, 2026 | 1.78 | 1.80 | 1.581 | 1.67 | 80814.00 |
| Oct 29, 2026 | 1.75 | 1.83 | 1.731 | 1.75 | 64775.00 |
| Oct 28, 2026 | 1.74 | 1.83 | 1.70 | 1.78 | 84880.00 |
| Oct 27, 2026 | 1.62 | 1.76 | 1.62 | 1.73 | 90740.00 |
| Oct 26, 2026 | 1.55 | 1.86 | 1.50 | 1.605 | 91184.00 |
| Oct 23, 2026 | 1.58 | 1.68 | 1.476 | 1.60 | 64377.00 |
| Oct 22, 2026 | 1.41 | 1.64 | 1.41 | 1.59 | 73526.00 |
| Oct 21, 2026 | 1.49 | 1.53 | 1.42 | 1.43 | 82148.00 |
| Oct 20, 2026 | 1.40 | 1.52 | 1.36 | 1.50 | 50611.00 |
| Oct 19, 2026 | 1.40 | 1.507 | 1.31 | 1.39 | 56355.00 |
| Oct 16, 2026 | 1.47 | 1.491 | 1.36 | 1.39 | 66060.00 |
| Oct 15, 2026 | 1.68 | 1.710 | 1.37 | 1.50 | 150409.0 |
| Oct 14, 2026 | 2.11 | 2.11 | 1.69 | 1.73 | 158741.0 |
| Oct 13, 2026 | 2.42 | 2.445 | 2.14 | 2.15 | 60522.00 |
| Oct 12, 2026 | 2.49 | 2.55 | 2.42 | 2.45 | 34899.00 |
| Oct 09, 2026 | 2.40 | 2.60 | 2.34 | 2.48 | 58460.00 |
| Oct 08, 2026 | 2.45 | 2.57 | 2.32 | 2.37 | 77298.00 |
| Oct 07, 2026 | 2.33 | 2.48 | 2.33 | 2.44 | 58117.00 |
| Oct 06, 2026 | 2.50 | 2.50 | 2.340 | 2.35 | 83785.00 |
| Oct 05, 2026 | 2.59 | 2.692 | 2.51 | 2.51 | 44156.00 |
| Oct 02, 2026 | 2.56 | 2.675 | 2.54 | 2.58 | 20808.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 57.46 |
| Oncolytics Biotech, Inc. | 0.4545 |
| Sangamo Therapeutics, Inc. | 0.114 |
| Sarepta Therapeutics, Inc. | 17.61 |
| Anixa Biosciences, Inc. | 3.02 |
Price Related Metrics
| PS Ratio | 3.510 |
| Price to Book Value | 0.5214 |
| Earnings Yield | -593.6% |
| Market Cap | 5.424M |